Skip to main content

Table 3 Mean differences between LDL-F and other LDL-C estimations in the total cohort, as well as in MetSyn and nonMetSyn individuals.

From: LDL cholesterol estimation in patients with the metabolic syndrome

  Mean difference (mg/dL) (bias %)
  Total (n = 179) MetSyn (n = 105) nonMetSyn (n = 74)
(LDL-F) – (LDL-P) 14 (-16–64) 16 (-16–64) 13 (-6–27)*
  10 (-13–33) 11 (-13–33) 9 (-5–18)**
(LDL-F) – (LDL-H) 9 (3–16) 10 (3–16) 8 (6–13)*
  6 (3–7) 6 (6–7) 6 (6–7)*
(LDL-F) – (LDL-A) 0.5 (-48–28) -4 (149-28) 8 (-27-24)*
  0.5 (-31–35) -3 (-31–35) 6 (-26-20)*
(LDL-F) – (LDL-W) 4 (-30–62) 7 (-30–62) 3 (-17–18)*
  3 (-25–33) 4 (-25–33) 3 (-16-11)**
(LDL-F) – (LDL-L) 16 (-48–70) 14 (-47–70) 16 (-48–51)
  10 (-48-37) 9 (-47-37) 12 (-48-33)
  1. Data are expressed as median (range).
  2. LDL: low-density lipoprotein, MetSyn: metabolic syndrome, LDL-F: LDL-cholesterol by Friedewald, LDL-P: LDL-cholesterol by Planella, LDL-H: LDL-cholesterol by Hattori, LDL-A: LDL-cholesterol by AMORIS, LDL-W: LDL-cholesterol by Wagner, LDL-L: LDL-cholesterol by Lipoprint LDL system. Mann-Whitney U test *p < 0.01 and **p < 0.05 compared to MetSyn individuals.